Skip to content
Aussie8 – Lifestyle
Author:
Regenerative Medical Technology Group
RMTG’s ISSCA Division Launches Integrative Fellowship in Point-of-Care Regenerative Medicine through ISSCA AI(TM) Strategy
September 17, 2026
Regenerative Medical Technology Group, Inc. Details Expanded ISSCA AI(TM) Clinical Intelligence Platform, Including Protocol-Native Engine, Structured Data Assets, and Multi-Line Commercial Model
September 14, 2026
RMTG Cellgenic Begins Commercial Activity in Colombia
September 8, 2026
Cellgenic Establishes Local Commercial Presence in Brazil
September 3, 2026
RMTG’s Cellgenic Commences Commercial Activity in Peru, Extending Its Latin American Footprint
September 1, 2026
RMTG’s Cellgenic Division Launches Natural Killer (NK) Cell Product Line for International Markets
August 29, 2026
RMTG More Than Quadruples Revenue and Gross Profit in Q2 2026 Versus Q2 2025, With Operating Income Surpassing $560,000
August 20, 2026
RMTG Provides Details for First-Ever Investor Call to Answer Shareholder Questions
August 19, 2026
RMTG Expands Cellgenic’s Cancún Laboratory Infrastructure with Two Additional ISO 7 Clean Rooms
August 18, 2026
RMTG to Hold First-Ever Investor Call to Discuss Second Quarter 2026 Results
August 5, 2026
1
2
Next Page
→